What is TG Therapeutics's deferred financing costs noncash?

TG Therapeutics (TGTX) reported deferred financing costs noncash of $0 in Q4 2025.

What does deferred financing costs noncash mean?

Non-cash expenses related to the amortization of costs incurred to secure financing.

How do you interpret deferred financing costs noncash?

This is a non-cash accounting adjustment and does not directly impact cash flow, but reflects the ongoing cost of capital structure maintenance.

How does deferred financing costs noncash compare across companies?

Common among companies with significant debt structures and capital market activities.

TG Therapeutics TGTX Deferred Financing Costs Noncash

Deferred Financing Costs Noncash at other companies

KKR Real Estate Finance TrustKREF

$0-100%

Claros Mortgage TrustCMTG

$18.51M+296%

Claros Mortgage TrustCMTG

$333K-82.0%

Claros Mortgage TrustCMTG

$6.49M+12.5%

GlaukosGKOS

$56K-83.7%

TPG RE Finance Trust, Inc.TRTX

——

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept tgtx:DeferredFinancingCostsNoncash.

The official record: TG Therapeutics’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's deferred financing costs noncash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's deferred financing costs noncash?: TG Therapeutics (TGTX) reported deferred financing costs noncash of $0 in Q4 2025.
What does deferred financing costs noncash mean?: Non-cash expenses related to the amortization of costs incurred to secure financing.
How do you interpret deferred financing costs noncash?: This is a non-cash accounting adjustment and does not directly impact cash flow, but reflects the ongoing cost of capital structure maintenance.
How does deferred financing costs noncash compare across companies?: Common among companies with significant debt structures and capital market activities.